Eli Lilly and Co (NYSE:LLY)
| 121.53 Delayed Data As of Dec 13 |  -0.17 / -0.14%Today’s Change | 101.36 Today|||52-Week Range 132.13 | +5.02% Year-to-Date |
Latest LLY News | Press Releases
| Better Buy: Eli Lilly vs. Merck Dec 14 / MotleyFool.com - Paid Partner Content | Here's Why Lexicon Pharmaceuticals Is Tumbling Today Dec 02 / MotleyFool.com - Paid Partner Content |
| Save Yourself the Migraine and Buy This 1 Pharma Stock Now Dec 06 / MotleyFool.com - Paid Partner Content | 3 Biotech Stocks With a Lot to Prove at ASH 2019 Dec 02 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 121.70 |
| Today’s open | 121.98 |
| Day’s range | 120.72 - 122.19 |
| Volume | 3,343,900 |
| Average volume (3 months) | 3,218,830 |
| Market cap | $116.6B |
Data as of 6:30pm ET, 12/13/2019
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +4.69% |
| Earnings growth (next 5 years) | +9.20% |
| Revenue growth (last year) | +7.36% |
| P/E ratio | 27.0 |
| Price/Sales | 4.87 |
| Price/Book | 13.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GSKGlaxoSmithKline | +0.05 | +0.11% |
| SNYSanofi | +0.28 | +0.57% |
| AZNAstraZeneca | +0.44 | +0.92% |
| ABBVAbbVie | -0.89 | -1.00% |
Data as of 6:30pm ET, 12/13/2019
Financials
| Next reporting date | January 30, 2020 |
| EPS forecast (this quarter) | $1.51 |
| Annual revenue (last year) | $24.6B |
| Annual profit (last year) | $3.2B |
| Net profit margin | 13.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
